Objective
During the last five years genetics and reproductive medicine have merged to form Reprogenetics and come to represent revolutionary possibilities for studying grave diseases and developing new therapies. Specific scenarios are developed that may result in the technical possibility to change the genetic constitution of humans and their descendants. In fact, in a limited way, some technologies may already do this. The overwhelming possibilities presented by such developments have been met with concern and reignited debate on question if men may be able to design and change the genetic structure of other men and if men may be able to create new human beings. The values at stake in these issues are often felt as deeply human and there is a widespread conviction that several of the new technical possibilities should be banned or at least placed under a moratorium no matter how promising they may be. The situation of a moratorium or ban might create a false impression of ethical clarity and yet, the content and strength of ethical arguments applied has not been analysed or made explicit. When not accompanied by a consistent study of conditions under which it may be lifted, a moratorium would no longer be a sign of ethical strength but of indecisiveness and a lack of ethical decision making. Still, in circles of private and academic research, science and technology continue to develop. This will result in gene therapy, cloning and stem cell research not guided by ethical and social reflection, but as an arbitrary result of unknown market forces and the private ambition of researchers and research institutes. The project will make a comparative analysis of the ethical aspects of hot issues in gene therapy and cloning, study the ambiguities and inconsistencies of current law and theory, try to strengthen them and, when needed, distinguish contexts that share names, but may have completely different ethical implications.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences genetics
- medical and health sciences clinical medicine gynaecology reproductive medicine
- medical and health sciences medical biotechnology genetic engineering gene therapy
- medical and health sciences medical biotechnology cells technologies stem cells
- social sciences law
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2003-SCIENCEANDSOCIETY-4
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
LEUVEN
Belgium
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.